RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CK Life Sciences Intl (Holdings) Stock

CK Life Sciences Intl (Holdings) EBIT 2024

CK Life Sciences Intl (Holdings) EBIT

246.76 M HKD

Ticker

775.HK

ISIN

KYG2176J1058

WKN

662762

In 2024, CK Life Sciences Intl (Holdings)'s EBIT was 246.76 M HKD, a -7.83% increase from the 267.71 M HKD EBIT recorded in the previous year.

The CK Life Sciences Intl (Holdings) EBIT history

YEAREBIT (undefined HKD)
2023246.76
2022267.71
2021265.39
202087.44
2019333.2
2018406.76
2017176.06
2016359.52
2015307.76
2014351.89
2013328.8
2012400
2011274.4
2010-5.7
2009-32.8
200838.6
200729.6
2006114.5
2005-16.9
2004-25.8

CK Life Sciences Intl (Holdings) Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into CK Life Sciences Intl (Holdings), a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by CK Life Sciences Intl (Holdings) from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects CK Life Sciences Intl (Holdings)’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of CK Life Sciences Intl (Holdings). Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into CK Life Sciences Intl (Holdings)’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing CK Life Sciences Intl (Holdings)’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on CK Life Sciences Intl (Holdings)’s growth potential.

CK Life Sciences Intl (Holdings) Revenue, EBIT and net profit per share

DateCK Life Sciences Intl (Holdings) RevenueCK Life Sciences Intl (Holdings) EBITCK Life Sciences Intl (Holdings) Net Income
20235.32 B undefined246.76 M undefined17.25 M undefined
20225.28 B undefined267.71 M undefined131.96 M undefined
20215.4 B undefined265.39 M undefined162.8 M undefined
20204.94 B undefined87.44 M undefined125.23 M undefined
20194.97 B undefined333.2 M undefined181.74 M undefined
20185.23 B undefined406.76 M undefined263 M undefined
20174.69 B undefined176.06 M undefined258.4 M undefined
20164.87 B undefined359.52 M undefined252.96 M undefined
20154.92 B undefined307.76 M undefined218.86 M undefined
20144.95 B undefined351.89 M undefined263.56 M undefined
20134.97 B undefined328.8 M undefined229 M undefined
20124.55 B undefined400 M undefined176.3 M undefined
20113.51 B undefined274.4 M undefined125.8 M undefined
20102.69 B undefined-5.7 M undefined208.6 M undefined
20092.68 B undefined-32.8 M undefined187.1 M undefined
20082.99 B undefined38.6 M undefined-351.8 M undefined
20072.09 B undefined29.6 M undefined117 M undefined
20062.2 B undefined114.5 M undefined102 M undefined
2005694.4 M undefined-16.9 M undefined12.2 M undefined
2004329.6 M undefined-25.8 M undefined1.9 M undefined

CK Life Sciences Intl (Holdings) stock margins

The CK Life Sciences Intl (Holdings) margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CK Life Sciences Intl (Holdings). The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CK Life Sciences Intl (Holdings).

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the CK Life Sciences Intl (Holdings)'s sales revenue. A higher gross margin percentage indicates that the CK Life Sciences Intl (Holdings) retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the CK Life Sciences Intl (Holdings)'s earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the CK Life Sciences Intl (Holdings)'s total revenue generated. When comparing the revenue margin year over year, investors can gauge the CK Life Sciences Intl (Holdings)'s growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the CK Life Sciences Intl (Holdings). Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the CK Life Sciences Intl (Holdings)'s financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

CK Life Sciences Intl (Holdings) Margin History

CK Life Sciences Intl (Holdings) Gross marginCK Life Sciences Intl (Holdings) Profit marginCK Life Sciences Intl (Holdings) EBIT marginCK Life Sciences Intl (Holdings) Profit margin
202330.76 %4.64 %0.32 %
202230.82 %5.07 %2.5 %
202130.17 %4.91 %3.01 %
202028.47 %1.77 %2.53 %
201932.35 %6.71 %3.66 %
201833.14 %7.77 %5.03 %
201732.9 %3.75 %5.51 %
201634.15 %7.38 %5.2 %
201535.41 %6.26 %4.45 %
201435.13 %7.1 %5.32 %
201335.04 %6.61 %4.61 %
201234.17 %8.8 %3.88 %
201133.61 %7.81 %3.58 %
201030.51 %-0.21 %7.74 %
200931.35 %-1.22 %6.98 %
200830.34 %1.29 %-11.76 %
200735.19 %1.42 %5.59 %
200637.65 %5.21 %4.64 %
200544.33 %-2.43 %1.76 %
200459.19 %-7.83 %0.58 %

CK Life Sciences Intl (Holdings) Aktienanalyse

What does CK Life Sciences Intl (Holdings) do?

CK Life Sciences International (Holdings) Inc (CKLS) is a leading company in the field of life sciences and biotechnology, founded in Hong Kong in 1994. It is a subsidiary of CK Hutchison Holdings, one of the largest conglomerates in Asia. CKLS operates in the business sectors of agricultural sciences, health sciences, and investment. The company has international offices in Australia, the USA, Canada, China, and Europe. The agricultural sciences division of CKLS focuses on research and development of plant-based technologies, including plant breeding, agricultural production, and biological pest control. CKLS specifically engages in the development of breeding techniques that enhance the speed, efficiency, and precision of plant breeding. The goal is to increase agricultural production and reduce the ecological footprint. CKLS also has its own brand of biological plant protection products called ABOUND, which provides protection against pests and diseases. The health sciences division of CKLS encompasses research and development of pharmaceuticals and dietary supplements. The company specializes in the development of dietary supplements made from natural ingredients that are intended to promote health and well-being. An example is the probiotic BioGaia, which is used to support digestive health and treat diarrhea. CKLS also engages in the research of herbal medicine and traditional Chinese medicine. The company has launched its own product line of traditional Chinese medicine, developed based on the millennia-old healing methods of Chinese medicine. The investment division of CKLS focuses on investing in companies and innovations that aim to improve life. For example, CKLS has invested in the US company StemCells, which specializes in the research and development of stem cell transplantation for neurological disorders. Overall, CKLS offers a wide range of products and services aimed at improving people's lives and health. Based on its research and development activities in the biotech industry, the company is working to solidify its leading role in the field of life sciences and biotechnology. In summary, CKLS is a leading company in the field of life sciences and biotechnology, operating in the sectors of agricultural sciences, health sciences, and investment. The company offers a wide range of products and services aimed at improving people's lives and health. CK Life Sciences Intl (Holdings) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing CK Life Sciences Intl (Holdings)'s EBIT

CK Life Sciences Intl (Holdings)'s Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of CK Life Sciences Intl (Holdings)'s EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

CK Life Sciences Intl (Holdings)'s EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in CK Life Sciences Intl (Holdings)’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about CK Life Sciences Intl (Holdings) stock

How much did CK Life Sciences Intl (Holdings) achieve in EBIT for the current year?

In the current year, CK Life Sciences Intl (Holdings) has achieved an EBIT of 246.76 M HKD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company CK Life Sciences Intl (Holdings).

How has the EBIT of CK Life Sciences Intl (Holdings) developed in recent years?

The EBIT of CK Life Sciences Intl (Holdings) has increased by -7.826% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company CK Life Sciences Intl (Holdings)?

The EBIT of CK Life Sciences Intl (Holdings) is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does CK Life Sciences Intl (Holdings) pay?

Over the past 12 months, CK Life Sciences Intl (Holdings) paid a dividend of 0.01 HKD . This corresponds to a dividend yield of about 1.78 %. For the coming 12 months, CK Life Sciences Intl (Holdings) is expected to pay a dividend of 0.01 HKD.

What is the dividend yield of CK Life Sciences Intl (Holdings)?

The current dividend yield of CK Life Sciences Intl (Holdings) is 1.78 %.

When does CK Life Sciences Intl (Holdings) pay dividends?

CK Life Sciences Intl (Holdings) pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of CK Life Sciences Intl (Holdings)?

CK Life Sciences Intl (Holdings) paid dividends every year for the past 13 years.

What is the dividend of CK Life Sciences Intl (Holdings)?

For the upcoming 12 months, dividends amounting to 0.01 HKD are expected. This corresponds to a dividend yield of 1.78 %.

In which sector is CK Life Sciences Intl (Holdings) located?

CK Life Sciences Intl (Holdings) is assigned to the 'Health' sector.

Wann musste ich die Aktien von CK Life Sciences Intl (Holdings) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CK Life Sciences Intl (Holdings) from 6/5/2023 amounting to 0.008 HKD, you needed to have the stock in your portfolio before the ex-date on 5/23/2023.

When did CK Life Sciences Intl (Holdings) pay the last dividend?

The last dividend was paid out on 6/5/2023.

What was the dividend of CK Life Sciences Intl (Holdings) in the year 2023?

In the year 2023, CK Life Sciences Intl (Holdings) distributed 0.01 HKD as dividends.

In which currency does CK Life Sciences Intl (Holdings) pay out the dividend?

The dividends of CK Life Sciences Intl (Holdings) are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CK Life Sciences Intl (Holdings)

Our stock analysis for CK Life Sciences Intl (Holdings) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CK Life Sciences Intl (Holdings) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.